diadenosine tetraphosphate has been researched along with cangrelor in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jacobson, KA; Jarvis, MF; Williams, M | 1 |
| Berny-Lang, MA; Chang, H; Dix, EJ; Frelinger, AL; Gremmel, T; Michelson, AD; Wright, GE; Yanachkov, IB; Yanachkova, MI | 1 |
| Boeynaems, JM; Communi, D; Gonzalez, NS; Labouret, C; Le Poul, E; Marteau, F; Savi, P | 1 |
1 review(s) available for diadenosine tetraphosphate and cangrelor
| Article | Year |
|---|---|
Purine and pyrimidine (P2) receptors as drug targets.
Topics: Adenosine Triphosphate; Animals; Drug Design; Humans; Ligands; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Pyrimidines; Receptors, Purinergic P2; Uridine Triphosphate | 2002 |
2 other study(ies) available for diadenosine tetraphosphate and cangrelor
| Article | Year |
|---|---|
New highly active antiplatelet agents with dual specificity for platelet P2Y1 and P2Y12 adenosine diphosphate receptors.
Topics: Animals; Chemistry Techniques, Synthetic; Dinucleoside Phosphates; Drug Evaluation, Preclinical; Drug Stability; Humans; Platelet Aggregation Inhibitors; Purinergic P2X Receptor Antagonists; Purinergic P2Y Receptor Antagonists; Rats; Receptors, Purinergic P2X1; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Structure-Activity Relationship | 2016 |
Pharmacological characterization of the human P2Y13 receptor.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Cell Membrane; CHO Cells; Cricetinae; Cyclic AMP; Female; GTP-Binding Protein alpha Subunits, Gi-Go; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Inositol Phosphates; Kinetics; Receptors, Purinergic P2; Thionucleotides | 2003 |